Want to see IN:MUKKA full AI Analyst Report?
MUKKA Stock Chart & Stats
₹22.65
₹0.29(1.28%)
At close: 4:00 PM EDT
₹22.65
₹0.29(1.28%)
Day’s Range― - ―
52-Week Range₹18.32 - ₹33.24
Previous CloseN/A
Volume131.60K
Average Volume (3M)116.42K
Market Cap
₹7.83B
Enterprise Value₹13.09K
Total Cash (Recent Filing)₹604.29M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)11.1
Beta0.72
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.31
Shares Outstanding300,000,000
10 Day Avg. Volume54,862
30 Day Avg. Volume116,415
Financial Highlights & Ratios
PEG Ratio0.87
Price to Book (P/B)1.11
Price to Sales (P/S)0.38
P/FCF Ratio-1.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthStrong multi-year revenue expansion, capped by a sharp 2026 rebound, indicates growing demand for the company’s marine protein ingredients. Continued top-line momentum can improve operating scale, support reinvestment, and strengthen its position across aquaculture and animal-feed markets.
Consistent ProfitabilityMaintaining positive profitability across the reported period shows that Mukka Proteins has a functioning earnings model despite modest margins. This provides an underlying base for expansion and demonstrates that revenue growth is translating into profits rather than being wholly loss-making.
Broad Feed ApplicationsThe company’s products address several animal-nutrition and aquaculture feed applications, including fish meal and fish oil demand. This breadth gives Mukka Proteins multiple end markets for its marine ingredients and reduces reliance on a single stated use case.
Bears Say
Weak Operating Cash FlowRepeatedly negative operating cash flow indicates that reported profits are not converting reliably into cash. The deeply negative 2026 result could constrain internally funded growth, increase reliance on external financing, and make the business more vulnerable when operating conditions weaken.
Persistent Free Cash OutflowConsistently negative free cash flow shows that expansion and investment needs exceed the cash generated by operations. Over the next several quarters, this may limit financial flexibility and require additional debt or equity, reducing the durability of growth if funding becomes harder to secure.
Rising Debt And Modest MarginsThe sharp increase in debt alongside modest net margins raises financing sensitivity as the balance sheet expands. Limited profitability buffers leave less room to absorb weaker pricing or operating volatility, while higher borrowing can increase pressure on future cash generation and capital allocation.
Mukka Proteins Limited News
MUKKA FAQ
What was Mukka Proteins Limited’s price range in the past 12 months?
Mukka Proteins Limited lowest stock price was ₹18.32 and its highest was ₹33.24 in the past 12 months.
What is Mukka Proteins Limited’s market cap?
Mukka Proteins Limited’s market cap is ₹7.83B.
When is Mukka Proteins Limited’s upcoming earnings report date?
Mukka Proteins Limited’s upcoming earnings report date is Nov 12, 2026 which is in 41 days.
How were Mukka Proteins Limited’s earnings last quarter?
Mukka Proteins Limited released its earnings results on Aug 12, 2026. The company reported ₹0.63 earnings per share for the quarter.
Is Mukka Proteins Limited overvalued?
According to Wall Street analysts Mukka Proteins Limited’s price is currently Overvalued.
Does Mukka Proteins Limited pay dividends?
Mukka Proteins Limited does not currently pay dividends.
What is Mukka Proteins Limited’s EPS estimate?
Mukka Proteins Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mukka Proteins Limited have?
Mukka Proteins Limited has 300,000,000 shares outstanding.
What happened to Mukka Proteins Limited’s price movement after its last earnings report?
Mukka Proteins Limited reported an EPS of ₹0.63 in its last earnings report. Following the earnings report the stock price went up 1.555%.
Which hedge fund is a major shareholder of Mukka Proteins Limited?
Currently, no hedge funds are holding shares in IN:MUKKA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Mukka Proteins Limited
Mukka Proteins Limited, based in Mangaluru, India, operates as a prominent manufacturer and supplier of protein products, extending its reach both domestically and internationally. The company specializes in a variety of fish-derived offerings, including fish meal, fish oil, and soluble fish paste. Expanding its portfolio, it also produces insect meal and insect oil. These versatile ingredients serve a wide range of industrial applications, notably in enhancing animal, poultry, and aquaculture feeds, and are furthermore utilized in pharmaceutical goods, soap production, leather tanneries, and paint manufacturing. The firm maintains a robust global presence, exporting its products to numerous countries across Asia and beyond, such as Bahrain, China, South Korea, and Vietnam, among others. Established in 1960, the company officially rebranded in August 2021, transitioning from its former identity, Mukka Sea Food Industries Limited, to its current name, Mukka Proteins Limited.
Technical Analysis
Avanti Feeds Limited
―
Hatsun Agro Product Limited
―
M K Proteins Limited
―
Parag Milk Foods Ltd.
―
SKM Egg Products Export (India) Ltd.
―